← Eichor
Study identifier: NCT07420127 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of Two Different Doses of Phenylephrine on Oxytocin Hemodynamic Effect

Condition: Phenylephrine · Cesarean Birth  ·  Sponsor: Rawalpindi Medical College

PhasePhase 4
Planned participants112
Who can joinFemale, 20 Years to 40 Years
Healthy volunteersYes

About this study

Cesarean section is one of the commonly performed surgical procedures in the world. Once baby is delivered during the surgical procedure anesthesiologist administer Oxytocin drug through IV cannula which helps the Uterus to contract so that excessive blood loss doesnt occur. But this is associated with fall in blood pressure frequently requiring administration of medications to treat low blood pressure. The most frequently used drug is phenylephrine which can administered along with oxytocin to prevent fall in blood pressure. This study will compare to different doses of Phenylephrine to prevent fall in blood pressure.

This description comes directly from the study's public registry record.

Talk to the study team

Farwa Javed Principal Investigator, MBBS  ·  +92 304 8954091  ·  farwajaved44@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Anesthesia, Holy Family Hospital, RawalpindiRawalpindi, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07420127